Stock Report

All about this stock under one free report Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Antares Pharma (ATRS) Key Ratios

Stock Card factsheet share-fund-plan-icon

$5.59

$0.00 (0.00%)

As on 24-May-2022 09:30EDT

Market cap

info icon

$955 Mln

Revenue (TTM)

info icon

$183 Mln

P/E Ratio

info icon

24.1

P/B Ratio

info icon

5.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -14.72 -1.25 15.67 35.26 28.72
EBIT -106.57 -155.45 179.19 171.44 36.07
Net Profit -107.10 -161.19 -31.90 109.88 31.83
EPS -107.31 -162.99 -33.85 104.93 30.28
Book Value -- -- 43.34 59.31 28.05
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-21Dec-20
EBIT-Margin info 14.752.0230.9733.859.16
Net Margin info 20.364.1623.1625.1737.55
Return on equity info 30.606.2726.8231.4064.74
Return on Capital info 22.274.77--25.6543.67
Return on Assets info 16.813.7214.1119.7032.55
Debt to Equity (x) info ----0.100.140.35

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
--
25.65
43.67
-2.53
-10.63
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

26.82

Higher than Peers by 21.88

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
26.82
31.40
64.74
-4.34
-17.96
Peer Median
4.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

14.11

Higher than Peers by 11.65

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
14.11
19.70
32.55
-1.83
-8.01
Peer Median
2.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

30.97

Higher than Peers by 22.49

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
30.97
33.85
9.16
1.23
-6.04
Peer Median
8.47
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

23.16

Higher than Peers by 18.49

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
23.16
25.17
37.55
-1.63
-10.21
Peer Median
4.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

15.67

Higher than Peers by 7.18

Year on year growth in net sales

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
15.67
0.23
0.21
0.95
0.17
Peer Median
8.49
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

179.19

Higher than Peers by 168.54

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
179.19
354.27
800.66
139.64
74.93
Peer Median
10.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-31.90

Lower than Peers by 45.45

Year on year growth in profit after tax

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
-31.90
-17.64
2,872.62
68.89
61.09
Peer Median
13.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-33.85

Lower than Peers by 54.36

Year on year growth in earnings per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
-33.85
-0.20
27.58
0.70
0.61
Peer Median
20.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

43.35

Higher than Peers by 36.34

Year on year growth in book value per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
43.35
--
--
--
--
Peer Median
7.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.10

Lower than Peers by 0.30

Total debt / Net worth

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
0.10
0.14
0.35
0.76
0.64
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.01

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
0.01
0.02
0.15
0.02
0.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.08

Higher than Peers by 0.25

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
3.08
2.74
2.00
3.35
2.62
Peer Median
2.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.87

Higher than Peers by 0.83

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
2.87
2.55
1.71
2.85
2.20
Peer Median
2.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

20.39

Higher than Peers by 15.43

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
20.39
--
3.62
0.43
-1.44
Peer Median
4.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

50.85

Higher than Peers by 34.39

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
50.85
45.12
33.66
34.96
46.29
Peer Median
16.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.61

Higher than Peers by 0.11

Sales / Average Total Assets

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
0.61
0.78
0.87
1.12
0.78
Peer Median
0.50
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
--
132.39
114.35
107.23
118.67
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
--
79.60
99.03
98.96
121.25
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
--
88.93
84.22
86.98
100.48
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
--
123.05
129.16
119.20
139.44
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

24.09

Lower than Peers by 20.36

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
24.09
13.50
12.07
-377.95
-65.55
Peer Median
44.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

5.43

Higher than Peers by 1.64

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
5.43
3.55
5.69
14.06
10.95
Peer Median
3.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

14.93

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
14.93
8.79
40.85
186.82
-380.17
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

955

Higher than Peers by 415

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Antares Pharma (ATRS)
955
--
--
--
--
Peer Median
540
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...